Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-28
1996-04-09
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546101, C07D41914, A61K 3147
Patent
active
055062326
ABSTRACT:
In the search for novel heteroanalogs of anthracendiones, 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione dimaleate salt (BBR 2778), was selected as the most promising compound. New methods of synthesis produce the compound in purity greater than 99%.
REFERENCES:
Krapcho et al, J. Med. Chem, vol. 28, pp. 1124-1126, 1985.
Krapcho et al., J. Med Chem, vol. 37, pp. 828-837, 1994.
DiDomenico Roberto
Spinelli Silvano
Boehringer Mannheim Italia S.p.A.
Davis Zinna N.
Rotman Alan L.
LandOfFree
6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-139204